Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 3;22(15):8349.
doi: 10.3390/ijms22158349.

Quercetin Administration Suppresses the Cytokine Storm in Myeloid and Plasmacytoid Dendritic Cells

Affiliations

Quercetin Administration Suppresses the Cytokine Storm in Myeloid and Plasmacytoid Dendritic Cells

Giulio Verna et al. Int J Mol Sci. .

Abstract

Dendritic cells (DCs) can be divided by lineage into myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs). They both are present in mucosal tissues and regulate the immune response by secreting chemokines and cytokines. Inflammatory bowel diseases (IBDs) are characterized by a leaky intestinal barrier and the consequent translocation of bacterial lipopolysaccharide (LPS) to the basolateral side. This results in DCs activation, but the response of pDCs is still poorly characterized. In the present study, we compared mDCs and pDCs responses to LPS administration. We present a broad panel of DCs secreted factors, including cytokines, chemokines, and growth factors. Our recent studies demonstrated the anti-inflammatory effects of quercetin administration, but to date, there is no evidence about quercetin's effects on pDCs. The results of the present study demonstrate that pDCs can respond to LPS and that quercetin exposure modulates soluble factors release through the same molecular pathway used by mDCs (Slpi, Hmox1, and AP-1).

Keywords: cytokines; dendritic cells; plasmacytoid; quercetin; slpi.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Representative density plots for dendritic cells (DCs) found in Peyer’s patches (PP) from wild-type (WT) (A) and Winnie mice (B), and in mesenteric lymphnodes (MLNs) from WT (D) and Winnie (E); 20,000 cells were acquired per each condition. Graphs represent percentages of the different populations of DCs in PP (C) and MLNs (F) in WT and Winnie mice; bars represent mean relative expression ± SEM (n = 4) for each genotype. * p < 0.05 **** p < 0.0001.
Figure 2
Figure 2
Representative density plots for CD11c, B220, and Ly6C staining in mDCs (A), myeloid dendritic cells (mDCs) stimulated with lipopolysaccharide (LPS) for 24 h (B), plasmacytoid dendritic cells (pDCs) (C), pDCs stimulated with LPS for 24 h (D). Bar plots for mean ± SEM (n = 4) showing the percentages of CD11c+B220+Ly6C+ cells (E), CD11c+CD80+ cells (F), and major histocompatibility complex II (MHCII) MFI (mean fluorescence intensity) (G) in control and after LPS stimulation for 24 h. Bar plots representing the mean ± SEM (n = 6) of toll-like receptor 4 (Tlr4) gene expression relative to control mDCs (H). * p < 0.05 *** p < 0.001 **** p < 0.0001.
Figure 3
Figure 3
Bar plots expressing the mean ± SEM (n = 4) for MHCII MFI and CD80 expression (A,B) and 7-Aminoactinomycin D (7-AAD) vitality staining (C) of mDCs and pDCs in baseline conditions and after stimulation with LPS and/or quercetin. *** p < 0.001 **** p < 0.0001.
Figure 4
Figure 4
Scatter plots expressing the mean ± SEM (n = 5) for secreted cytokines of mDCs and pDCs in baseline conditions and after stimulation with LPS and/or quercetin. * p < 0.05 ** p < 0.005 *** p < 0.001 **** p < 0.0001; $ p < 0.05 $$ p < 0.005 $$$ p < 0.001 $$$$ p < 0.0001; * LPS vs. quercetin + LPS; $ mDCs vs. pDCs.
Figure 5
Figure 5
Scatter plots expressing the mean ± SEM (n = 5) for secreted chemokines of mDCs and pDCs in baseline conditions and after stimulation with LPS and/or quercetin. * p < 0.05 *** p < 0.001 **** p < 0.0001; $$$ p < 0.001 $$$$ p < 0.0001; * LPS vs. quercetin + LPS; $ mDCs vs. pDCs.
Figure 6
Figure 6
Scatter plots expressing the mean ± SEM (n = 5) for secreted growth factors of mDCs and pDCs in baseline conditions and after stimulation with LPS and/or quercetin. **** p < 0.0001; $ p < 0.05 $$$$ p < 0.0001; * LPS vs. quercetin + LPS; $ mDCs vs. pDCs.
Figure 7
Figure 7
Molecular pathways activated in mDCs and pDCs 6 h after LPS stimulation and/or quercetin administration. Bar plots representing the mean ± SEM (n = 6) of each gene expression relative to control mDCs. * p < 0.05 ** p < 0.005 **** p < 0.0001; $$ p < 0.005 $$$ p < 0.001 $$$$ p < 0.0001; * LPS vs. quercetin + LPS; $ mDCs vs. pDCs.

Similar articles

Cited by

References

    1. Rutella S., Locatelli F. Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 2011;17:3761–3775. doi: 10.3748/wjg.v17.i33.3761. - DOI - PMC - PubMed
    1. Eri R., Chieppa M. Messages from the Inside. The Dynamic Environment that Favors Intestinal Homeostasis. Front. Immunol. 2013;4:323. doi: 10.3389/fimmu.2013.00323. - DOI - PMC - PubMed
    1. Hart A.L., Al-Hassi H.O., Rigby R.J., Bell S.J., Emmanuel A.V., Knight S.C., Kamm M.A., Stagg A.J. Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases. Gastroenterology. 2005;129:50–65. doi: 10.1053/j.gastro.2005.05.013. - DOI - PubMed
    1. Stagg A.J. Intestinal Dendritic Cells in Health and Gut Inflammation. Front. Immunol. 2018;9:2883. doi: 10.3389/fimmu.2018.02883. - DOI - PMC - PubMed
    1. Sun T., Nguyen A., Gommerman J.L. Dendritic Cell Subsets in Intestinal Immunity and Inflammation. J. Immunol. 2020;204:1075–1083. doi: 10.4049/jimmunol.1900710. - DOI - PubMed

MeSH terms